Ketazolam Adamed (Ketazolam)

Ketazolam belongs to the benzodiazepine class and acts on the central nervous system to relieve anxiety‑related symptoms and muscle tension.

• Anxiety disorders: reduces excessive worry, tension and autonomic symptoms associated with generalized anxiety.
• Muscle spasm: relaxes skeletal muscle tone and alleviates painful spasms caused by musculoskeletal conditions.

• Ketazolam is a positive allosteric modulator of the GABA‑A receptor. By binding to a specific benzodiazepine site, it enhances the affinity of the receptor for the inhibitory neurotransmitter GABA, increasing chloride ion influx and producing a net inhibitory effect on neuronal firing, which underlies its anxiolytic and muscle‑relaxant properties.

Ketazolam may cause a range of adverse reactions, some of which are more frequently observed than others.

Common Side Effects

• Drowsiness: feeling unusually sleepy or fatigued.
• Dizziness: sensation of light‑headedness or unsteadiness.
• Impaired coordination: reduced motor control and clumsiness.
• Memory impairment: difficulty recalling recent events.
• Headache: mild to moderate cranial pain.

Serious or Rare Side Effects

• Respiratory depression: slowed or shallow breathing, especially with concomitant depressants.
• Paradoxical agitation: unexpected increase in anxiety, aggression or hostility.
• Dependence and withdrawal: risk of physical dependence with prolonged use and potential seizures upon abrupt cessation.
• Severe hypotension: marked drop in blood pressure leading to faintness.
• Allergic reactions: rash, itching, swelling or anaphylaxis.

Ketazolam requires careful consideration of patient‑specific factors and safe handling practices.

• Elderly patients: increased sensitivity to sedative effects; start with the lowest effective dose.
• Hepatic impairment: reduced metabolism may prolong drug action; monitor closely.
• Abrupt discontinuation: avoid sudden stop to prevent withdrawal symptoms; taper under medical supervision.
• Contraindicated in acute narrow‑angle glaucoma: may exacerbate intra‑ocular pressure.
• Caution with other CNS depressants: additive sedation can occur.
• Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Ketazolam can interact with several medication classes, influencing its safety and efficacy.

Major Interactions (Avoid)

• Other benzodiazepines: additive CNS depression.
• Opioids: heightened risk of respiratory depression.
• Alcohol: synergistic sedative effect.
• Barbiturates: profound respiratory and CNS depression.
• CNS depressants (e.g., antihistamines, antipsychotics): increased sedation.

Moderate Interactions (Monitor Closely)

• SSRIs and other antidepressants: possible increased sedation.
• Antiepileptic drugs: may alter seizure threshold.
• CYP3A4 inhibitors (e.g., ketoconazole): increased plasma levels of ketazolam.
• CYP3A4 inducers (e.g., rifampicin): reduced efficacy.
• Antihistamines: enhanced drowsiness.